VKTX
7:05 AM
Viking Therapeutics to Participate at Upcoming Investor Conferences
vikingtherapeutics.com
News Updates
Thu, May 21, 2026
1 updatesTue, May 12, 2026
1 updatesVKTX
7:05 AM
Viking Therapeutics Presents Data from its 13-Week Phase 2 VENTURE-Oral Dosing Trial of VK2735 at European Congress on Obesity (ECO) 2026
Presentation / Abstract • Phase 2ECO poster presentation Tue, May 12, 2026vikingtherapeutics.com
Tue, May 5, 2026
1 updatesVKTX
7:05 AM
Viking Therapeutics Announces Two Poster Presentations at European Congress on Obesity (ECO) 2026
Presentation / Abstract • Phase 2vikingtherapeutics.com
Wed, Apr 29, 2026
1 updatesVKTX
4:05 PM
Viking Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Enrollment • Phase 3vikingtherapeutics.com
Wed, Apr 22, 2026
1 updatesVKTX
4:35 PM
Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026
vikingtherapeutics.com
Fri, Apr 10, 2026
1 updatesVKTX
7:30 AM
Viking Therapeutics to Participate at Upcoming Investor Conferences
vikingtherapeutics.com
Thu, Mar 26, 2026
1 updatesVKTX
7:05 AM
Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
Enrollment • Phase 3vikingtherapeutics.com
Thu, Mar 5, 2026
1 updatesVKTX
4:03 PM
Viking Therapeutics to Participate at Upcoming Investor Conferences
vikingtherapeutics.com